Position in ARGX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$5,566
+$1,185 QoQ
Shares Held
6
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#463
of 506 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026First Command Advisory Services, Inc. holds $118,503 across 11 Biotechnology names. ARGX ranks #4 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARQT |
Arcutis Biotherapeutics, Inc.
|
2,000 | $52,440 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
157 | $47,261 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
14 | $6,954 | |
| 4 | ARGX |
Argenx SE
This page
|
6 | $5,566 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5 | $3,117 | |
| 6 | GMAB |
Genmab A/S
|
43 | $1,181 | |
| 7 | INSM |
INSMED Inc
|
8 | $852 | |
| 8 | EXEL |
Exelixis, Inc.
|
12 | $652 |
All Filings in ARGX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,566 | 6 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $4,381 | 6 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $5,045 | 6 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $4,425 | 6 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $3,307 | 6 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $3,551 | 6 | Shares | Sole | 2025-05-02 | |
| No filing history on record for this holder in this stock. | ||||||